Abstract
In surgical intensive care patients, monitoring of procalcitonin (PCT) is a helpful tool for guiding antibiotic treatment when compared with a standard eight day regimen. This may contribute to an optimised antibiotic regimen with beneficial effects on microbial resistance and costs in intensive care medicine.
Level of evidence: 1+ (RCT with a low risk of bias)